PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Macdonald, Robert Loch
TI  - No Significant Improvement in Vasospasm-Related Morbidity or All-Cause Mortality with Clazosentan after aSAH
DP  - 2011 Apr 01
TA  - MD Conference Express
PG  - 14--15
VI  - 11
IP  - 1
4099  - http://mdc.sagepub.com/content/11/1/14.short
4100  - http://mdc.sagepub.com/content/11/1/14.full
AB  - Results from the Clazosentan in Reducing Vasospam-Related Morbidity and Mortality in Adult Patients with Aneurysmal Subarachnoid Hemorrhage Treated By Surgical Clipping [CONSCIOUS-2; NCT00558311] study indicate that the use of the endothelin receptor antagonist clazosentan does not significantly improve vasospasm-related morbidity or all-cause mortality after aneurysmal subarachnoid hemorrhage.